HYCEMZO
Live / Applied — Third extension granted (statement of use) (as of 22 Jan 2026)
What this means for you
Not registered yet, but its 15 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98500793
- Mark type
- Stylized text
- Filed
- 15 Apr 2024
- Published for opposition
- 23 Jul 2024
- Attorney of record
- B. Brett Heavner
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for human use, namely medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction
Owner
- Cytokinetics, Incorporated, South San Francisco, CA, US
- Cytokinetics, Incorporated, South San Francisco, CA, US
Prosecution history
- 23 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jan 2026 — SOU EXTENSION 3 GRANTED
- 22 Jan 2026 — SOU EXTENSION 3 FILED
- 22 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 17 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Dec 2025 — SOU EXTENSION 2 GRANTED
- 16 Dec 2025 — SOU EXTENSION 2 FILED
- 16 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jan 2025 — SOU EXTENSION 1 GRANTED
- 09 Jan 2025 — SOU EXTENSION 1 FILED
- 09 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Dec 2024 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 20 Aug 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED